Expression of transgenes in midbrain dopamine neurons using the tyrosine hydroxylase promoter.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 437, doi. 10.1038/gt.2008.148
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2009 AND VI 16 AND IP 3
Results: 17
1
2
Systemic delivery of IL-10 by an AAV vector prevents vascular remodeling and end-organ damage in stroke-prone spontaneously hypertensive rat.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 383, doi. 10.1038/gt.2008.151
- By:
- Publication type:
- Article
3
A cell penetrating heme oxygenase protein protects heart graft against ischemia/reperfusion injury.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 320, doi. 10.1038/gt.2008.162
- By:
- Publication type:
- Article
4
Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 359, doi. 10.1038/gt.2008.164
- By:
- Publication type:
- Article
5
Generation of optimized and urokinase-targeted oncolytic Sendai virus vectors applicable for various human malignancies.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 392, doi. 10.1038/gt.2008.167
- By:
- Publication type:
- Article
6
Tailoring the AAV vector capsid for gene therapy.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 311, doi. 10.1038/gt.2008.170
- By:
- Publication type:
- Article
7
AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 426, doi. 10.1038/gt.2008.174
- By:
- Publication type:
- Article
8
Foamy virus as a gene transfer vector to the central nervous system.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 448, doi. 10.1038/gt.2008.171
- By:
- Publication type:
- Article
9
Lentivectors encoding immunosuppressive proteins genetically engineer pancreatic β-cells to correct diabetes in allogeneic mice.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 340, doi. 10.1038/gt.2008.172
- By:
- Publication type:
- Article
10
Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet’s disease-like mouse model.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 415, doi. 10.1038/gt.2008.180
- By:
- Publication type:
- Article
11
Identification of the murine firefly luciferase-specific CD8 T-cell epitopes.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 441, doi. 10.1038/gt.2008.177
- By:
- Publication type:
- Article
12
A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 376, doi. 10.1038/gt.2008.179
- By:
- Publication type:
- Article
13
Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 349, doi. 10.1038/gt.2008.173
- By:
- Publication type:
- Article
14
An adenoviral vector-based mucosal vaccine is effective in protection against botulism.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 367, doi. 10.1038/gt.2008.181
- By:
- Publication type:
- Article
15
Integration of functional bacterial artificial chromosomes into human cord blood-derived multipotent stem cells.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 404, doi. 10.1038/gt.2008.187
- By:
- Publication type:
- Article
16
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 329, doi. 10.1038/gt.2008.188
- By:
- Publication type:
- Article
17
Basic research tries to decrease the risks of translational medicine.
- Published in:
- Gene Therapy, 2009, v. 16, n. 3, p. 309, doi. 10.1038/gt.2009.15
- By:
- Publication type:
- Article